|
04 Apr 2020 |
Update on GSK actions to support the global response to COVID-19
|
|
03 Apr 2020 |
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
|
|
02 Apr 2020 |
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
|
|
01 Apr 2020 |
Vaxart Provides Update on its Oral COVID-19 Vaccine Program
|
|
01 Apr 2020 |
VBI Vaccines Announces Collaboration with the National Research Council of Canada to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS
|
|
31 Mar 2020 |
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
|
|
30 Mar 2020 |
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
|
|
27 Mar 2020 |
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
|
|
26 Mar 2020 |
INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
|
|
26 Mar 2020 |
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
|
|
26 Mar 2020 |
Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
|
|
26 Mar 2020 |
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
|
|
25 Mar 2020 |
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
|
|
25 Mar 2020 |
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
|
|
24 Mar 2020 |
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
|
|
24 Mar 2020 |
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
|
|
24 Mar 2020 |
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
|
|
24 Mar 2020 |
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
|
|
23 Mar 2020 |
Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
|
|
23 Mar 2020 |
COVID-19 vaccine development
|
|
23 Mar 2020 |
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
|
|
19 Mar 2020 |
CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine
|
|
19 Mar 2020 |
SELLAS Announces Positive Antigen-Specific Immune Response Data for Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast from Phase 2 VADIS Study
|
|
19 Mar 2020 |
Versatope Selects Influenza Vaccine Candidate for Clinical Development
|
|
19 Mar 2020 |
Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform
|
